Monday, 2 December 2024 Reading time : 2 minutes

There are roughly 20 trading days left in the financial year 2024. The Swiss market as a whole, as measured by the SPI, has performed solidly so far, with a year-to-date gain of 7.6% (as of 29 November, total return). Swiss blue chips have performed even better, gaining 9.1% over the same period, as the SMI shows. 

The pharmaceutical supplier Lonza continues to lead the SMI, with its shares up almost 50% year-to-date. It is followed by Swiss Re (+37.6%) and Holcim (+35.9%). After eleven months of trading, a handful of SMI stocks are down, namely Kühne + Nagel (-27.3%), Nestlé (-21.6%), Sika (-16.7%), Logitech (-10.4%) and Geberit (-1.6%). Among the top ten SPI performers are Accelleron (+88.1%), Swissquote (69%) and Sulzer (+54.6%).

In an international comparison, the SMI holds up with the European blue-chip index EuroStoxx 50 (+9.8%). The US stock market, on the other hand, is in a different league: the S&P 500 is up a whopping 28% since the beginning of the year. The benchmark index rose sharply following Donald Trump's election victory, posting its best monthly performance of the year in November with a gain of 5.7%.

Barrier Reverse Convertible on SPI Winners
9.00% p.a. BRC on Accelleron, Sulzer and Swissquote
Barrier: 68%
Valor: 139 434 501

Barrier Reverse Convertible on SMI Winners
8.40% p.a. BRC auf Lonza, Swiss Re und Holcim
Barrier: 68%
Valor: 139 434 501

Barrier Reverse Convertible on SMI Laggards
8.50% p.a. BRC on Kuehne + Nagel, Nestle and Logitech
Barrier: 68%
Valor: 139 434 502

Indicative terms

 

Disclaimer
This communication is for marketing purposes. It is neither an offer nor an invitation to submit an offer, to purchase or to subscribe to securities and does not constitute investment advice. You should consult your advisors before making an investment decision. Forward-looking statements are subject to known and unknown risks, uncertainties and other factors that may cause the actual results, financial condition, development or performance of the issuer to be materially different from any future results, financial condition, development or performance expressed or implied by such statements. The present document has not been drawn up by the research department as defined in the rules of the “Directives on the Independence of Financial Research” published by the Swiss Bankers Association, hence these rules do not apply to this document. If securities are mentioned in the communication, the base prospectus, the final terms and any key information document may be obtained free of charge from Zürcher Kantonalbank, Bahnhofstrasse 9, 8001 Zurich, VRIS, and from www.zkb.ch/finanzinformationen.
© 2024 Zürcher Kantonalbank. All rights reserved.